U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 26, 2019 - February 2, 2020
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 26, 2019 - February 2, 2020

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 01/27/2020
Location: Washington, DC
Subject: Bipartisan Policy Center and Alliance for Cell Therapy Now Mtg; Roundtable - Regenerative Medicine: Real World Evidence to Measure Outcomes, Support Regulatory Payment, and Patient Decision Making
FDA Participant/Group: PETER MARKS;
Non FDA Participant/Group: Patients, academia, industry, government, and other invited guests

Event Date: 01/28/2020
Location: Silver Spring, MD
Subject: CBD Listening Session with National Sanitation Foundation (NSF) International
FDA Participant/Group: SHARON MAYL; CARA WELCH; PATRICK CANNON; REBECCA GOLDBERG; RACHEL OSTERMAN; CASSANDRA TAYLOR; APRIL ALEXANDROW; DOUGLAS THROCKMORTON; PATRICK COURNOYER; JUN LI; MICHAEL LEVY; STEVEN TAVE; LINDA KATZ;
Non FDA Participant/Group: Amanda Phelka, Bradley Lampe, David Trosin, Harold Chase, Jesse D. Miller, Sylvia Laman (NSF International);

Event Date: 01/29/2020
Location: Washington, DC
Subject: Symposium on the Interface of Regulatory & Analytical Sciences for Biotechnology Health Products; Keynote Speaker: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, and industry

Event Date: 01/30/2020
Location: Washington, DC
Subject: WashingtonExec Healthcare Council; Speaker: Technology Modernization Action Plan (TMAP)
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, and other invited guests

Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 01/28/2020
Location: Silver Spring, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: CAITLIN BOON; LARRY MORRIS;
Non FDA Participant/Group: Kyle Kinner, Sandra Eskin (The Pew Charitable Trusts);

Event Date: 01/28/2020
Location: College Park, MD
Subject: Produce Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Several representatives from the produce industry

Event Date: 01/29/2020
Location: Silver Spring, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Several members from the National Association of State Departments of Agriculture

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/28/2020
Location: Bethesda, MD
Subject: National Center for Advancing Translational Sciences/Center for Biologics Evaluation and Research Workshop; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff members
Non FDA Participant/Group: Several leaders, key stakeholders and innovators interested in rare disease gene therapies and adeno-associated virus manufacturing capacity

Event Date: 01/31/2020
Location: Newark, NJ
Subject: Talent Development Ideation Meeting; Speaker: FDA’s Perspective on the Workforce in Cell and Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from the New Jersey Innovation Institute and the Alliance for Regenerative Medicine

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 01/29/2020
Location: Silver Spring, MD
Subject: Medical Devices Symposium; Speaker: Opening Remarks
FDA Participant/Group: CESAR PEREZ; NEIL MAFNAS; ETHNY OBAS; NANCY PRESSLY; MELISSA TORRES; MARK ABDOO; KENNETH CHEN; KATHERINE SERRANO; LORETTA CHI;
Non FDA Participant/Group: National regulatory authorities of regional reference (Mexico, Argentina, Colombia, Chile, Cuba, and Canada)

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event